Our Technology Platform

How Our Platform Works

Auravita’s technology integrates three core innovations:

1.Lipid-Raft Targeting

A proprietary modular chemistry that allows therapeutic antibodies to interact with and modulate lipid-raft organization during cell activation.

2. Controlled Modulation of Immune Signaling

By influencing lipid-raft coalescence, our therapeutics can adjust receptor clustering and downstream signaling strength, reducing excessive inflammatory activation while preserving normal immune function

3. Platform Modularity

The chemistry is payload-agnostic and disease-agnostic, enabling rapid adaptation for:

  • Autoimmune & Inflammatory Disorders

  • Immune-metabolic diseases

  • Oncology-adjacent inflammation

  • Neuroinflammatory & proteinopathy-related signaling dysfunction

  • Other conditions driven by lipid-raft dysregulation